In particular, paclitaxel is known to trigger the production of proinflammatory cytokines such as interleukin (IL)-6 and IL-8 via binding to Toll-like receptor 4 (TLR4) on myeloid cells and many cancer cells (7). The gene discussed is TLR4; the disease is cancer.